Hodgkin Disease 
Welcome,         Profile    Billing    Logout  

5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hodgkin Disease
NCT02259556: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas

Recruiting
1/2
30
RoW
CART30, anti-CD30 CAR T cells
Chinese PLA General Hospital
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
10/18
10/29
NCT00960050: Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Active, not recruiting
1
173
US
polymorphism analysis, laboratory biomarker analysis, medical chart review, assessment of therapy complications
Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI)
Leukemia, Lymphoma, Methemoglobinemia, Nonmalignant Neoplasm
05/15
 
NCT00423826: Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

No Longer Available
N/A
US
Busulfan, Busulfex®, Myleran®, Cytarabine, DepoCyt(TM), Liposomal Ara-C, Fludarabine phosphate, Fludara, mycophenolate mofetil, Cellcept, tacrolimus, Advagraf, Prograf, Protopic, allogeneic hematopoietic stem cell transplantation, umbilical cord blood transplantation, total-body irradiation
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
01/15
01/15
EAP, NCT00720603: This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.

No Longer Available
N/A
US
Plerixafor, AMD3100, Mozobil
Genzyme, a Sanofi Company
Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma
 
 
EuroNet-PHL-C2, NCT02797717: Treatment for Classical Hodgkin Lymphoma in Children and Adolescents

Recruiting
N/A
2200
RoW
Radiotherapy:, Vincristine, Etoposide, Prednisone, Doxorubicin, Dacarbazine, Cyclophosphamide
GALIA AVRAHAMI, University of Giessen
Classical Hodgkins Lymphoma in Children and Adolescents.
12/22
12/27

Download Options